Abnormal expression of PFDN4 in colorectal cancer: A novel marker for prognosis

Annals of Surgical Oncology

Volumn 17, Issue 11, 2010, Pages 3030-3036

  Miyoshi, Norikatsu ^a   Ishii, Hideshi ^a,b   Mimori, Koshi ^b   Nishida, Naohiro ^b   Tokuoka, Masayoshi ^a   Akita, Hirofumi ^a   Sekimoto, Mitsugu ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLUOROURACIL; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PFDN4; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; AGED; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL GROWTH; CELL INVASION; CLINICAL ASSESSMENT; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; SURGICAL TECHNIQUE;

AGED; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MOLECULAR CHAPERONES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 78049474162     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1138-5     Document Type: Article

References (29)

1. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387 (Pubitemid 351521864)
2. OM Jones SK John N Horseman, et al. 2007 Cause and place of death in patients dying with colorectal cancer Colorectal Dis 9 253 257 1:STN:280:DC%2BD2s%2FpvFOnsA%3D%3D 10.1111/j.1463-1318.2006.01131.x 17298624 (Pubitemid 46477029)
3. SI Kohno C Luo A Nawa, et al. 2007 Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus Cancer Gene Ther 14 918 926 1:CAS:528:DC%2BD2sXhtFChur%2FP 10.1038/sj.cgt.7701070 17693992 (Pubitemid 47558955)
4. M Yamasaki I Takemasa T Komori, et al. 2007 The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer Int J Oncol 30 129 138 1:CAS:528:DC%2BD2sXhtFyrtLc%3D 17143521
5. JC Aliaga C Deschenes JF Beaulieu, et al. 1999 Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells Am J Physiol 277 3 Pt 1 G631 G641 1:CAS:528:DyaK1MXmt1altrc%3D 10484389
6. T Yamatodani L Ekblad E Kjellen, et al. 2009 Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines J Cancer Res Clin Oncol 135 395 402 1:CAS:528:DC%2BD1MXht1Ogu7g%3D 10.1007/s00432-008-0475-2 18813952
7. C Collins S Volik D Kowbel, et al. 2001 Comprehensive genome sequence analysis of a breast cancer amplicon Genome Res 11 1034 1042 1:CAS:528:DC%2BD3MXkt12rurY%3D 10.1101/gr.GR1743R 11381030 (Pubitemid 32834548)
8. IE Vainberg SA Lewis H Rommelaere, et al. 1998 Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin Cell 93 863 873 1:CAS:528:DyaK1cXjsl2ru7s%3D 10.1016/S0092-8674(00)81446-4 9630229 (Pubitemid 28257591)
9. Japanese Society for Cancer of the Colon and Rectum. Guidelines for therapy of colorectal cancer (in Japanese). Tokyo: Kanehara Shuppan; 2005.
10. Sobin LH, Witedkind CH. International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997. p. 66-9.
11. TG Christensen B Burke DL Dexter N Zamcheck 1985 Ultrastructural evidence of dimethylformamide-induced differentiation of cultured human colon carcinoma cells. Increased expression of desmosomes Cancer 56 1559 1565 1:STN:280:DyaL2M3ot1SitA%3D%3D 10.1002/1097-0142(19851001)56:7<1559::AID- CNCR2820560716>3.0.CO;2-T 4027892 (Pubitemid 15228502)
12. K Ishizu N Sunose K Yamazaki, et al. 2007 Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells Biol Pharm Bull 30 1779 1783 1:CAS:528:DC%2BD2sXhtFels7bI 10.1248/bpb.30.1779 17827739 (Pubitemid 47403265)
13. S Aznavoorian LA Liotta HZ Kupchik 1990 Characteristics of invasive and noninvasive human colorectal adenocarcinoma cells J Natl Cancer Inst 82 1485 1492 1:STN:280:DyaK3czmt1Crtw%3D%3D 10.1093/jnci/82.18.1485 2391719
14. K Mimori M Mori T Shiraishi, et al. 1997 Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma Br J Cancer 76 531 536 1:CAS:528:DyaK2sXlvV2nsLc%3D 9275032 (Pubitemid 27331220)
15. M Mori RJ Staniunas GF Barnard, et al. 1993 The significance of carbonic anhydrase expression in human colorectal cancer Gastroenterology 105 820 826 1:STN:280:DyaK3szms1Whuw%3D%3D 8359652
16. T Tsujino I Seshimo H Yamamoto, et al. 2007 Stromal myofibroblasts predict disease recurrence for colorectal cancer Clin Cancer Res 13 2082 2090 1:CAS:528:DC%2BD2sXjs12rt78%3D 10.1158/1078-0432.CCR-06-2191 17404090 (Pubitemid 46649876)
17. AM Lagers CF Sier LJ Hawinkels, et al. 2008 MMP-2 geno-phenotype is prognostic factor for colorectal cancer survival, whereas MMP-9 is not Br J Cancer 98 1820 1823 10.1038/sj.bjc.6604380 (Pubitemid 351748845)
18. M Iijima Y Kano T Nohno M Namba 1996 Cloning of cDNA with possible transcription factor activity at the G1-S phase transition in human fibroblast cell lines Acta Med Okayama 50 73 77 1:CAS:528:DyaK28XjtlSgsLo%3D 8744932
19. WJ Hansen NJ Cowan WJ Welch 1999 Prefoldin-nascent chain complexes in the folding of cytoskeletal proteins J Cell Biol 145 265 277 1:CAS:528: DyaK1MXislSgt7c%3D 10.1083/jcb.145.2.265 10209023 (Pubitemid 29198300)
20. G Hodgson JH Hager S Volik, et al. 2001 Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas Nat Genet 29 459 464 1:CAS:528:DC%2BD3MXovFCqsL4%3D 10.1038/ng771 11694878 (Pubitemid 34326698)
21. T Andre E Quinaux C Louvet, et al. 2007 Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1 J Clin Oncol 25 3732 3738 1:CAS:528:DC%2BD2sXhtVeqt7fK 10.1200/JCO.2007.12.2234 17704423 (Pubitemid 47372615)
22. BM Wolpin RJ Mayer 2008 Systemic treatment of colorectal cancer Gastroenterology 134 1296 1310 1:CAS:528:DC%2BD1cXntVWhtL0%3D 10.1053/j.gastro.2008.02.098 18471507 (Pubitemid 351615376)
23. M Kornmann A Formentini C Ette, et al. 2008 Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment Eur J Surg Oncol 34 1316 1321 1:STN:280:DC%2BD1cjhsFCjug%3D%3D 18313881
24. OF Bathe S Dowden F Sutherland, et al. 2004 Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma BMC Cancer 4 32 10.1186/1471-2407-4-32 15245580 (Pubitemid 40180254)
25. AM Lacy JC Garcia-Valdecasas S Delgado, et al. 2002 Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial Lancet 359 2224 2229 10.1016/S0140-6736(02)09290-5 12103285 (Pubitemid 34717975)
26. JC Weeks H Nelson S Gelber, et al. 2002 Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial JAMA 287 321 328 10.1001/jama.287.3.321 11790211
27. Clinical Outcomes of Surgical Therapy Study Group 2004 A comparison of laparoscopically assisted and open colectomy for colon cancer N Engl J Med 350 2050 2059 10.1056/NEJMoa032651 (Pubitemid 38596556)
28. DG Jayne PJ Guillou H Thorpe, et al. 2007 Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group J Clin Oncol 25 3061 3068 10.1200/JCO.2006.09.7758 17634484 (Pubitemid 47224732)
29. M Koshariya RB Jagad J Kawamoto, et al. 2007 An update and our experience with metastatic liver disease Hepatogastroenterology 54 2232 2239 18265640